Drug Trial Radar · NCT04191577
Study of CVN424 in Parkinson's Disease Patients With Motor Fluctuations
Last checked: Nov 19, 2026Latest source record: Jul 3, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
136
Actual
Start
Dec 2, 2019
Primary completion
Nov 6, 2021
Study completion Dec 13, 2021
Sponsor
- Lead sponsor
- Cerevance Beta, Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 10, 2019
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 30 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 2 study, randomized, double-blind, placebo-controlled, multicenter study of oral CVN424 at two dose levels (low-dose and high-dose) in Parkinson's disease (PD) patients with motor fluctuations.
Conditions
- Parkinson Disease
Interventions
CVN424 Low DoseDrug
CVN424
CVN424 High DoseDrug
CVN424
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants With Treatment-emergent Adverse Events (TEAEs) Related to Study DrugTime frame: Up to Day 35
Locations
21 sites in 1 country. Site status is shown where the registry gives one.
Collaborative Neuroscience Network, LLC
Long Beach, California
SC3 Research - Pasadena
Pasadena, California
Parkinson's Disease and Movement Disorders Center of Boca Raton
Boca Raton, Florida
Nova Clinical Research
Bradenton, Florida
Premier Clinical Research Institute
Miami, Florida
Parkinson's Disease Treatment Center of SW Florida
Port Charlotte, Florida
Accel Research Site - Brain and Spine Institute of Port Orange
Port Orange, Florida
USF Parkinson's Disease and Movement Disorders Center
Tampa, Florida
Charter Research
Winter Park, Florida
NeuroTrials Research, Inc.
Atlanta, Georgia
Parkinson's Disease and Movement Disorder Center
Kansas City, Kansas
Boston Clinical Trials
Roslindale, Massachusetts
Quest Research Institute
Farmington Hills, Michigan
Bio Behavioral Health
Toms River, New Jersey
New York Neurology Associates
New York, New York
M3 Wake Research
Raleigh, North Carolina
Optimed Research Ltd
Columbus, Ohio
Neurology Diagnostics Inc
Dayton, Ohio
Prisma Health
Greenville, South Carolina
Central Texas Neurology Consultants
Round Rock, Texas
Inland Northwest Research, LLC
Spokane, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.